Initial guidance for an update of the National Vaccine Plan: a letter report to the National Vaccine Program Office
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C.
National Academies Press
2008
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | "This letter report contains the committee's initial guidance to the National Vaccine Program Office and its partners as they draft the update to the National Vaccine Plan." Includes bibliographical references Background -- Features of the 1994 national vaccine plan -- The committee's approach to reviewing the plan -- Changes since 1994 -- Progress since 1994 -- Guidance for developing a new national vaccine plan -- Process issues -- Content areas -- Concluding remarks -- References -- Statement of task -- Meeting one agenda -- 1994 national vaccine plan goals, objectives, and anticipated outcomes This book is the Institute of Medicine's response to the first part of the statement of task asking for a review of the 1994 National Vaccine Plan. The Committee on the Review of Priorities in the National Vaccine Plan reviewed the goals, objectives, strategies, and anticipated outcomes presented in the plan; their findings are contained in this book.In the first section of the book, the committee examines what has changed in the broader social, policy, and economic context of vaccine development and immunization, and highlights several areas where noteworthy progress has been made, particularly by federal agencies. The committee acknowledges that progress in developing and delivering vaccines has benefited from essential contributions by other stakeholders, including researchers, manufacturers, state and local public health agencies, and health care providers. In the second section of the book, the committee uses what it learned from reviewing the 1994 plan and the process of preparing it to distill key elements. Based on these elements, the committee offers guidance to NVPO and its partners on developing the update to the national vaccine plan |
| Beschreibung: | 1 Online-Ressource (x, 28 p.) |
| ISBN: | 030912199X 1281726842 9780309121996 9781281726841 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043085917 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2008 |||| o||u| ||||||eng d | ||
| 020 | |a 030912199X |c PDF |9 0-309-12199-X | ||
| 020 | |a 1281726842 |9 1-281-72684-2 | ||
| 020 | |a 9780309121996 |c PDF |9 978-0-309-12199-6 | ||
| 020 | |a 9781281726841 |9 978-1-281-72684-1 | ||
| 035 | |a (OCoLC)320326305 | ||
| 035 | |a (DE-599)BVBBV043085917 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 614.4/7 |2 22 | |
| 245 | 1 | 0 | |a Initial guidance for an update of the National Vaccine Plan |b a letter report to the National Vaccine Program Office |c Committee on the Review of Priorities in the National Vaccine Plan, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies |
| 246 | 1 | 3 | |a Letter report to the National Vaccine Program Office |
| 264 | 1 | |a Washington, D.C. |b National Academies Press |c 2008 | |
| 300 | |a 1 Online-Ressource (x, 28 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a "This letter report contains the committee's initial guidance to the National Vaccine Program Office and its partners as they draft the update to the National Vaccine Plan." | ||
| 500 | |a Includes bibliographical references | ||
| 500 | |a Background -- Features of the 1994 national vaccine plan -- The committee's approach to reviewing the plan -- Changes since 1994 -- Progress since 1994 -- Guidance for developing a new national vaccine plan -- Process issues -- Content areas -- Concluding remarks -- References -- Statement of task -- Meeting one agenda -- 1994 national vaccine plan goals, objectives, and anticipated outcomes | ||
| 500 | |a This book is the Institute of Medicine's response to the first part of the statement of task asking for a review of the 1994 National Vaccine Plan. The Committee on the Review of Priorities in the National Vaccine Plan reviewed the goals, objectives, strategies, and anticipated outcomes presented in the plan; their findings are contained in this book.In the first section of the book, the committee examines what has changed in the broader social, policy, and economic context of vaccine development and immunization, and highlights several areas where noteworthy progress has been made, particularly by federal agencies. The committee acknowledges that progress in developing and delivering vaccines has benefited from essential contributions by other stakeholders, including researchers, manufacturers, state and local public health agencies, and health care providers. In the second section of the book, the committee uses what it learned from reviewing the 1994 plan and the process of preparing it to distill key elements. Based on these elements, the committee offers guidance to NVPO and its partners on developing the update to the national vaccine plan | ||
| 610 | 1 | 7 | |a National Vaccine Plan (U.S.) |2 fast |
| 610 | 1 | 4 | |a National Vaccine Plan (U.S.) |
| 610 | 2 | 4 | |a National Vaccine Plan (U.S.) |
| 650 | 7 | |a MEDICAL / Health Risk Assessment |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Epidemiology |2 bisacsh | |
| 650 | 7 | |a Communicable diseases / Prevention |2 fast | |
| 650 | 7 | |a Immunization |2 fast | |
| 650 | 7 | |a Vaccination |2 fast | |
| 650 | 4 | |a Immunization Programs / Guideline / United States | |
| 650 | 4 | |a Immunization Programs / organization & administration / United States | |
| 650 | 4 | |a Health Priorities / Guideline / United States | |
| 650 | 4 | |a Communicable Disease Control / United States | |
| 650 | 4 | |a Vaccines / United States | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Vaccination |z United States | |
| 650 | 4 | |a Immunization |z United States | |
| 650 | 4 | |a Communicable diseases |z United States |x Prevention | |
| 651 | 4 | |a USA | |
| 710 | 2 | |a Institute of Medicine (U.S.) |b Committee on the Review of Priorities in the National Vaccine Plan |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 0-309-12198-1 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-0-309-12198-9 |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=233572 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028510109 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=233572 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=233572 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175482203144192 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043085917 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)320326305 (DE-599)BVBBV043085917 |
| dewey-full | 614.4/7 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 614 - Forensic medicine; incidence of disease |
| dewey-raw | 614.4/7 |
| dewey-search | 614.4/7 |
| dewey-sort | 3614.4 17 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04635nmm a2200649zc 4500</leader><controlfield tag="001">BV043085917</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2008 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">030912199X</subfield><subfield code="c">PDF</subfield><subfield code="9">0-309-12199-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1281726842</subfield><subfield code="9">1-281-72684-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309121996</subfield><subfield code="c">PDF</subfield><subfield code="9">978-0-309-12199-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781281726841</subfield><subfield code="9">978-1-281-72684-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)320326305</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043085917</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">614.4/7</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Initial guidance for an update of the National Vaccine Plan</subfield><subfield code="b">a letter report to the National Vaccine Program Office</subfield><subfield code="c">Committee on the Review of Priorities in the National Vaccine Plan, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Letter report to the National Vaccine Program Office</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (x, 28 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"This letter report contains the committee's initial guidance to the National Vaccine Program Office and its partners as they draft the update to the National Vaccine Plan."</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Background -- Features of the 1994 national vaccine plan -- The committee's approach to reviewing the plan -- Changes since 1994 -- Progress since 1994 -- Guidance for developing a new national vaccine plan -- Process issues -- Content areas -- Concluding remarks -- References -- Statement of task -- Meeting one agenda -- 1994 national vaccine plan goals, objectives, and anticipated outcomes</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">This book is the Institute of Medicine's response to the first part of the statement of task asking for a review of the 1994 National Vaccine Plan. The Committee on the Review of Priorities in the National Vaccine Plan reviewed the goals, objectives, strategies, and anticipated outcomes presented in the plan; their findings are contained in this book.In the first section of the book, the committee examines what has changed in the broader social, policy, and economic context of vaccine development and immunization, and highlights several areas where noteworthy progress has been made, particularly by federal agencies. The committee acknowledges that progress in developing and delivering vaccines has benefited from essential contributions by other stakeholders, including researchers, manufacturers, state and local public health agencies, and health care providers. In the second section of the book, the committee uses what it learned from reviewing the 1994 plan and the process of preparing it to distill key elements. Based on these elements, the committee offers guidance to NVPO and its partners on developing the update to the national vaccine plan</subfield></datafield><datafield tag="610" ind1="1" ind2="7"><subfield code="a">National Vaccine Plan (U.S.)</subfield><subfield code="2">fast</subfield></datafield><datafield tag="610" ind1="1" ind2="4"><subfield code="a">National Vaccine Plan (U.S.)</subfield></datafield><datafield tag="610" ind1="2" ind2="4"><subfield code="a">National Vaccine Plan (U.S.)</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Health Risk Assessment</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Epidemiology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Communicable diseases / Prevention</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunization</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaccination</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunization Programs / Guideline / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunization Programs / organization & administration / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health Priorities / Guideline / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Communicable Disease Control / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccination</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunization</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Communicable diseases</subfield><subfield code="z">United States</subfield><subfield code="x">Prevention</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Committee on the Review of Priorities in the National Vaccine Plan</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">0-309-12198-1</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-0-309-12198-9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=233572</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028510109</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=233572</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=233572</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV043085917 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:16:59Z |
| institution | BVB |
| isbn | 030912199X 1281726842 9780309121996 9781281726841 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028510109 |
| oclc_num | 320326305 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (x, 28 p.) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | National Academies Press |
| record_format | marc |
| spelling | Initial guidance for an update of the National Vaccine Plan a letter report to the National Vaccine Program Office Committee on the Review of Priorities in the National Vaccine Plan, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies Letter report to the National Vaccine Program Office Washington, D.C. National Academies Press 2008 1 Online-Ressource (x, 28 p.) txt rdacontent c rdamedia cr rdacarrier "This letter report contains the committee's initial guidance to the National Vaccine Program Office and its partners as they draft the update to the National Vaccine Plan." Includes bibliographical references Background -- Features of the 1994 national vaccine plan -- The committee's approach to reviewing the plan -- Changes since 1994 -- Progress since 1994 -- Guidance for developing a new national vaccine plan -- Process issues -- Content areas -- Concluding remarks -- References -- Statement of task -- Meeting one agenda -- 1994 national vaccine plan goals, objectives, and anticipated outcomes This book is the Institute of Medicine's response to the first part of the statement of task asking for a review of the 1994 National Vaccine Plan. The Committee on the Review of Priorities in the National Vaccine Plan reviewed the goals, objectives, strategies, and anticipated outcomes presented in the plan; their findings are contained in this book.In the first section of the book, the committee examines what has changed in the broader social, policy, and economic context of vaccine development and immunization, and highlights several areas where noteworthy progress has been made, particularly by federal agencies. The committee acknowledges that progress in developing and delivering vaccines has benefited from essential contributions by other stakeholders, including researchers, manufacturers, state and local public health agencies, and health care providers. In the second section of the book, the committee uses what it learned from reviewing the 1994 plan and the process of preparing it to distill key elements. Based on these elements, the committee offers guidance to NVPO and its partners on developing the update to the national vaccine plan National Vaccine Plan (U.S.) fast National Vaccine Plan (U.S.) MEDICAL / Health Risk Assessment bisacsh MEDICAL / Epidemiology bisacsh Communicable diseases / Prevention fast Immunization fast Vaccination fast Immunization Programs / Guideline / United States Immunization Programs / organization & administration / United States Health Priorities / Guideline / United States Communicable Disease Control / United States Vaccines / United States Medizin Vaccination United States Immunization United States Communicable diseases United States Prevention USA Institute of Medicine (U.S.) Committee on the Review of Priorities in the National Vaccine Plan Sonstige oth Erscheint auch als Druckausgabe 0-309-12198-1 Erscheint auch als Druckausgabe 978-0-309-12198-9 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=233572 Aggregator Volltext |
| spellingShingle | Initial guidance for an update of the National Vaccine Plan a letter report to the National Vaccine Program Office National Vaccine Plan (U.S.) fast National Vaccine Plan (U.S.) MEDICAL / Health Risk Assessment bisacsh MEDICAL / Epidemiology bisacsh Communicable diseases / Prevention fast Immunization fast Vaccination fast Immunization Programs / Guideline / United States Immunization Programs / organization & administration / United States Health Priorities / Guideline / United States Communicable Disease Control / United States Vaccines / United States Medizin Vaccination United States Immunization United States Communicable diseases United States Prevention |
| title | Initial guidance for an update of the National Vaccine Plan a letter report to the National Vaccine Program Office |
| title_alt | Letter report to the National Vaccine Program Office |
| title_auth | Initial guidance for an update of the National Vaccine Plan a letter report to the National Vaccine Program Office |
| title_exact_search | Initial guidance for an update of the National Vaccine Plan a letter report to the National Vaccine Program Office |
| title_full | Initial guidance for an update of the National Vaccine Plan a letter report to the National Vaccine Program Office Committee on the Review of Priorities in the National Vaccine Plan, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies |
| title_fullStr | Initial guidance for an update of the National Vaccine Plan a letter report to the National Vaccine Program Office Committee on the Review of Priorities in the National Vaccine Plan, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies |
| title_full_unstemmed | Initial guidance for an update of the National Vaccine Plan a letter report to the National Vaccine Program Office Committee on the Review of Priorities in the National Vaccine Plan, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies |
| title_short | Initial guidance for an update of the National Vaccine Plan |
| title_sort | initial guidance for an update of the national vaccine plan a letter report to the national vaccine program office |
| title_sub | a letter report to the National Vaccine Program Office |
| topic | National Vaccine Plan (U.S.) fast National Vaccine Plan (U.S.) MEDICAL / Health Risk Assessment bisacsh MEDICAL / Epidemiology bisacsh Communicable diseases / Prevention fast Immunization fast Vaccination fast Immunization Programs / Guideline / United States Immunization Programs / organization & administration / United States Health Priorities / Guideline / United States Communicable Disease Control / United States Vaccines / United States Medizin Vaccination United States Immunization United States Communicable diseases United States Prevention |
| topic_facet | National Vaccine Plan (U.S.) MEDICAL / Health Risk Assessment MEDICAL / Epidemiology Communicable diseases / Prevention Immunization Vaccination Immunization Programs / Guideline / United States Immunization Programs / organization & administration / United States Health Priorities / Guideline / United States Communicable Disease Control / United States Vaccines / United States Medizin Vaccination United States Immunization United States Communicable diseases United States Prevention USA |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=233572 |
| work_keys_str_mv | AT instituteofmedicineuscommitteeonthereviewofprioritiesinthenationalvaccineplan initialguidanceforanupdateofthenationalvaccineplanaletterreporttothenationalvaccineprogramoffice AT instituteofmedicineuscommitteeonthereviewofprioritiesinthenationalvaccineplan letterreporttothenationalvaccineprogramoffice |